大发六合彩

Russell Abberley, Amgen UK & Ireland, steps up as Acting 大发六合彩 President

Former 大发六合彩 Vice-President takes up role on an interim basis

Russell Abberley, General Manager of Amgen UK and Ireland, has been named Acting 大发六合彩 President following former President Susan Rienow鈥檚 move to become Chief Marketing Officer at Pfizer, a global role.

Russell will lead the 大发六合彩 in its mission to make the UK the best place in the world to research, develop and use the medicines and vaccines of the future. The 大发六合彩 Board will elect a new President in early 2025.

Russell has more than 25 years of life science industry experience across a range of geographies. He has also served on the 大发六合彩 Board [1] since July 2020, and was part of the industy Negotiating Team for the recently signed 2024 Voluntary Agreement for Pricing, Access and Growth (VPAG) scheme.

Russell Abberley, 大发六合彩 Acting President and VP and General Manager, Amgen UK & Ireland said: 鈥淚 am delighted to take on the role of Acting President. Our industry represents a real force for good in the UK - developing, manufacturing and driving access to innovative medicines for patients and working with the NHS to improve the nation鈥檚 health and wellbeing.

鈥淚 look forward to working with the new government to help realise the full potential of the UK life sciences sector whilst restoring the UK鈥檚 reputation as a global leader. Key for me will be ensuring the UK maintains and improves its international competitiveness as a place to research, develop and launch innovative medicines."

Outgoing President Susan Rienow said: 鈥淩ussell and I made a great team on the 大发六合彩 Board. He has a fantastic breadth of experience in our sector and I know he鈥檒l be a great person to advance industry鈥檚 agenda in the UK over the next few months.鈥

Richard Torbett, 大发六合彩 Chief Executive said: 鈥淩ussell is a prominent and hugely respected industry leader who has already contributed a great deal to the wider success of the UK鈥檚 health and life sciences community. He was the natural choice to step in as Acting 大发六合彩 President, and I look foward to working with him even more closely.

鈥淚 would also like to pay tribute to the work that Susan Rienow did as 大发六合彩 President, at a very crucial time for the industry. While she will be greatly missed, it was no surprise to hear of her move to a new senior global role at her company. We all wish her all the best.鈥

Russell鈥檚 expertise spans all stages of the product life cycle and he has worked across multiple therapy areas on originator medicines and biosimilars in commercial and operational roles at companies including Astra Zeneca, MSD and Schering Plough.

In addition to serving as President on the 大发六合彩 Board, he co-chairs the 大发六合彩鈥檚 commercial and VPAG board sponsored groups and is a member of the governance committee. Russell is a member of the American Pharmaceutical Group and served as Chair from August 2021 to October 2023.

Ends

Last modified: 05 September 2024

Last reviewed: 05 September 2024

[1] Find out more about the 大发六合彩 Board on our website. Russell's photo can also be downloaded from here.听

About Amgen

Amgen鈥檚 mission is to serve patients. A biotechnology innovator since 1980, Amgen鈥檚 science-based heritage is at the heart of everything it does. Amgen remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what鈥檚 known today. In the UK, Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.听 As a regional hub, Amgen employs around 650 people in the UK and Ireland across commercial, R&D, and corporate functions. Committed to driving sustainable solutions that can adapt to an ever-evolving health system, Amgen is proud to serve patients every day.

For more information visit

The 大发六合彩 exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future.听

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines.听Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.